Trident Lifeline Share Price Today | Stock Price & Trident Lifeline Share Screener
Track the current Trident Lifeline share price and stock price live with TickJournal's free stock screener. Check TLL 52-week chart for the annual price range and momentum. Use the Trident Lifeline stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Trident Lifeline opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Key Statistics and Valuation Ratios
Over the trailing twelve months the company reported revenue of ₹34 and net income of ₹5, with EBITDA of ₹9, an operating margin of 25.0% and a profit margin of 14.7%.
Trident Lifeline Share Price Chart
Track the current stock price of Trident Lifeline with an interactive chart. Analyse TLL share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Trident Lifeline stock quote in one place.
Trident Lifeline Company Profile - Fundamental Screener
Screen Trident Lifeline company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for TLL shares across the equity market and its stock price history, plus the wider market trend.
The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE0MKA01014.
Company Details
Classification
Identifiers and Leadership
Trident Lifeline Balance Sheet Screener
Screen TLL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.
For 2026, total assets were ₹237, up from ₹156 in 2025.
Latest statistics put total assets at ₹237 and shareholder funds at ₹100, with a leverage ratio of 0.62.
| Item | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
Assets |
|||||
| Total Assets | 237 | 156 | 87 | 63 | 14 |
| Current Assets | 140 | 90 | 52 | 49 | 11 |
| Fixed Assets | 73 | 44 | 21 | 3 | 1 |
Liabilities |
|||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 41 | 33 | 13 | 4 | 2 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Shareholders' Equity |
|||||
| Total Equity | 100 | 70 | 54 | 47 | 5 |
| Share Capital | 12 | 12 | 12 | 12 | 8 |
| Reserves & Surplus | 89 | 53 | 40 | 34 | -3 |
Trident Lifeline Income Statement Screener - Profit & Revenue Analysis
Screen Trident Lifeline income statement and profit fundamentals. Analyze TLL quarterly results. Trident Lifeline reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.
For 2026-Jun, revenue was ₹34 and net profit was ₹5, equal to earnings per unit of ₹4.27, at an operating margin of 25%.
In that period expenses were ₹25, interest cost ₹1 and tax ₹2. The next period listed, 2026-Mar, shows revenue of ₹52 and net profit of ₹7.
| Item | 2026-Jun | 2026-Mar | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2023-Sept | 2023-Jun | 2023-Mar | 2022-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and Expenses | |||||||||||||||
| Revenue | 34 | 52 | 30 | 33 | 25 | 36 | 12 | 16 | 14 | 21 | 7 | 10 | 9 | 9 | 10 |
| Expenses | 25 | 39 | 21 | 25 | 18 | 26 | 8 | 11 | 11 | 17 | 6 | 8 | 7 | 7 | 7 |
Operating Costs and Margins | |||||||||||||||
| EBITDA | 9 | 13 | 10 | 9 | 7 | 10 | 5 | 5 | 4 | 4 | 2 | 3 | 2 | 3 | 2 |
| Operating Profit % | 25.00% | 22.00% | 20.00% | 22.00% | 22.00% | 25.00% | 34.00% | 26.00% | 19.00% | 12.00% | 20.00% | 22.00% | 20.00% | 23.00% | 21.00% |
| Depreciation | 2 | 1 | 3 | 1 | 2 | 3 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit and Earnings | |||||||||||||||
| Profit Before Tax | 7 | 11 | 6 | 7 | 4 | 6 | 4 | 4 | 3 | 3 | 1 | 2 | 2 | 2 | 2 |
| Tax | 2 | 4 | 1 | 2 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 |
| Net Profit | 5 | 7 | 5 | 5 | 3 | 6 | 3 | 3 | 2 | 2 | 1 | 2 | 1 | 2 | 2 |
| EPS | 4.27 | 5.76 | 3.72 | 4.27 | 2.66 | 6.15 | 2.42 | 2.69 | 1.99 | 1.41 | 0.94 | 1.48 | 1.22 | 1.72 | 1.77 |
Trident Lifeline Cash Flow Screener - Liquidity Fundamentals
Screen TLL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.
In 2025-March, operating activities used ₹10, and net cash flow was an outflow of ₹4.
Over the same period, investing activities used ₹14 and financing activities provided ₹20.
| Item | 2025-March | 2024-March | 2023-March | 2022-March |
|---|---|---|---|---|
Cash from Operations and Investing | ||||
| Operating Activities | -10 | 2 | -19 | 0 |
| Investing Activities | -14 | -20 | -10 | 0 |
Financing and Net Cash | ||||
| Financing Activities | 20 | 11 | 42 | 1 |
| Net Cash Flow | -4 | -7 | 14 | 0 |
Trident Lifeline Shareholding Pattern Screener
See Trident Lifeline shareholding pattern with promoter, FII, and DII holdings. Check Trident Lifeline promoter holding and ownership changes for TLL on TickJournal, and see how institutional stock price moves affect the market.
In 2026-Mar, promoters held 62.85%, foreign institutions 7.24%, domestic institutions 0.27% and the public 18.67%, spread across 607 shareholders.
The shareholder count was 607 in 2026-Mar, compared with 709 in 2026-Jun.
| Item | 2026-Mar | 2026-Jun | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun |
|---|---|---|---|---|---|---|---|---|
Promoter Holding | ||||||||
| Promoter Holding | 62.85% | 62.59% | 63.04% | 63.04% | 63.11% | 64.11% | 67.48% | 65.51% |
Institutional Investors | ||||||||
| FII Holding | 7.24% | 5.25% | 6.62% | 7.21% | 7.71% | 7.04% | 6.02% | 6.02% |
| DII Holding | 0.27% | 0.26% | 0.09% | 0.39% | 0.41% | 0.35% | 0.00% | 0.00% |
Government, Public and Others | ||||||||
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 18.67% | 20.58% | 18.26% | 17.90% | 17.63% | 17.29% | 16.39% | 18.37% |
| Other Holding | 10.97% | 11.31% | 11.99% | 11.45% | 11.14% | 11.22% | 10.10% | 10.10% |
| Shareholder Count | 607 | 709 | 534 | 549 | 554 | 549 | 500 | 502 |
Dividend Yield Screener - Share Price & Share Analysis
Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Trident Lifeline. Trident Lifeline dividend yield can be compared with peers and other stocks in the market.
Trident Lifeline Stock Index Membership - Nifty & Sensex
See which indices include Trident Lifeline stock. Check TLL index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.
Complete Index List
Trident Lifeline Market Events Screener - Corporate Actions
Get Trident Lifeline corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Trident Lifeline stock events that may affect TLL share price, along with derivatives, futures and options activity and sector gainers.
12 corporate actions are listed, the most recent entry being Annual General Meeting dated September 26, 2026, with a record date of September 26, 2026.
It is followed by Quarterly Result Announcement dated July 29, 2026 and Quarterly Result Announcement dated May 7, 2026.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-09-26 | 2026-09-26 | Annual General Meeting | NA | 49.94% |
| 2026-07-29 | 2026-07-29 | Quarterly Result Announcement | NA | 0.21% |
| 2026-05-07 | 2026-05-07 | Quarterly Result Announcement | NA | -0.97% |
| 2026-01-17 | 2026-01-17 | Quarterly Result Announcement | NA | 5.78% |
| 2025-11-11 | 2025-11-11 | Quarterly Result Announcement | NA | 1.43% |
| 2025-09-27 | 2025-09-27 | Annual General Meeting | NA | -0.35% |
| 2025-07-28 | 2025-07-28 | Quarterly Result Announcement | NA | 1.19% |
| 2025-05-09 | 2025-05-09 | Extraordinary General Meeting | NA | 13.60% |
| 2025-04-28 | 2025-04-28 | Quarterly Result Announcement | NA | 5.19% |
| 2025-01-22 | 2025-01-22 | Quarterly Result Announcement | NA | 5.83% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 4.93% |
| 2024-09-20 | 2024-09-20 | Annual General Meeting | NA | 18.05% |
Trident Lifeline Competitors Screener - Peer Stocks Comparison
Screen TLL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.
The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical | 447,476 | 36.44 | 61,674 | 12.69% | 11,565 | 47.42 |
| Divis Laboratories | 250,363 | 86.51 | 11,067 | 13.95% | 2,568 | 58.71 |
| Torrent Pharmaceuticals | 186,152 | 85.91 | 13,886 | 20.34% | 2,138 | 48.14 |
| Zydus Life Science | 120,798 | 26.32 | 27,658 | 17.64% | 5,026 | 61.81 |
| Cipla | 111,426 | 33.44 | 29,045 | 2.24% | 3,870 | 44.03 |
| Laurus Labs | 106,838 | 99.70 | 6,868 | 22.01% | 890 | 58.00 |
| Mankind Pharma | 105,107 | 48.73 | 14,636 | 14.85% | 1,938 | 64.24 |
| Dr Reddys Laboratories | 104,492 | 32.05 | 35,059 | 3.90% | 4,158 | 69.59 |
| Aurobindo Pharma | 97,682 | 26.36 | 34,145 | 5.56% | 3,503 | 54.69 |
| Lupin | 93,829 | 16.99 | 29,039 | 26.75% | 5,356 | 34.02 |
Trident Lifeline Company Announcements - News & Reports Screener
Screen TLL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.
20 recent announcements are listed, the latest dated .
The next most recent announcements are dated October 5, 2026 and October 5, 2026.
| Date | Update | Actions |
|---|---|---|
| Board Meeting Intimation for Consideraration And Evaluate The Proposal To Raise Funds | - | |
| 2026-10-05 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2026-10-05 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-10-03 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2026-10-03 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-10-01 | REPLY TO THE CLARIFICATION SOUGHT ON PRICE MOVEMENT | - |
| 2026-09-30 | Clarification sought from Trident Lifeline Ltd | - |
| 2026-09-16 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-09-08 | Disclosure Under Regulation 30 Of SEBI (LODR)- Intimation Of Award | - |
| 2026-09-05 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-09-04 | Reg. 34 (1) Annual Report. | - |
| 2026-09-04 | Notice Of 13Th Annual General Meeting Of The Company | - |
| 2026-09-04 | Revision Of Book Closure And Cut-Off Date For The 13Th Annual General Meeting | - |
| 2026-09-01 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-08-31 | Announcement under Regulation 30 (LODR)-Allotment | - |
| 2026-08-31 | Board Meeting Outcome for Outcome Of Board Meeting Held On Today I.E. On August 31 2026 In Terms Of Second Proviso To Regulation 30(6) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-08-31 | Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015-Intimation Of Award | - |
| 2026-08-26 | Intimation Of Book Closure And Cut-Off Date For 13Th AGM | - |
| 2026-08-26 | 13Th Annual General Meeting Scheduled To Be Held On 26.09.2026 | - |
| 2026-08-26 | Outcome Of Board Meeting Held On 26.08.2026 | - |
Frequently Asked Questions
How is the company valued right now?
The P/E ratio is 22.69 and the P/B ratio is 4.85, with earnings per unit of ₹16.32. Market capitalisation stands at ₹486.55 Cr. The company operates in the Healthcare sector, in the Pharmaceuticals industry, so compare these ratios with its sector peers in the table above.
About This Data
Key statistics were last updated on October 6, 2026. This page covers 5 balance sheet periods, 15 income statement periods, 4 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.